Stage IIIRadiotherapyLong-term follow-upAttempts to increase survival in stage III ovarian cancer patients with minimal residual disease at second-look laparotomy have included consolidation radiotherapy. We pr
Treatment with bevacizumab (Avastin) plus chemotherapy resulted in a non-statistically significant improvement in overall survival (OS) of nearly 5 months compared with chemotherapy alone for women with platinum-sensitive recurrent ovarian cancer, according to results from the phase III GOG0213 trial pre...
Like many other cancers, when ovarian cancer is found at an early stage (for example, localized to the ovary or fallopian tube) the average survival rate of five years is very good (about 93%); most women at stage 1 will still be alive at five years. However, the five-year average s...
Surgery for platinum-sensitive, relapsed ovarian cancer (PSROC) is widely practiced but had contradictory survival outcomes in previous studies. In this multicenter, open-label, phase 3 trial, women with PSROC, and having had one previous therapy and no platinum-based chemotherapy (platinum-free...
Merck’s anti-PD-1 therapy, met its overall survival (OS) endpoint, in combination with chemotherapy as pre-operative (neoadjuvant) treatment and then continuing as a single agent after surgery (adjuvant) for the treatment of patients ...
Residual plots for the ovarian cancer data set Figures 1Aillustrates a plot of the Martingale residuals against the patient's age, with a Kernel smoother marked as the dashed line.Figure 1Bshows the Martingale residuals plotted against FIGO stage, with the median within each stage represented by...
Cancerof the lung, like allcancers, results from an abnormality in the body's basic unit of life, the cell. Normally, the body maintains a system of checks and balances on cell growth so that cells divide to produce new cells only when new cells are needed. Disruption of this system of...
Serum CA 125 regression after cytoreductive surgery and during the first three courses of chemotherapy was studied in 60 ovarian cancer patients and compared to known prognostic factors. Various methods reported in the literature to calculate a CA 125 half-live value were compared. Using two exponent...
This randomized clinical trial of women with ovarian cancer compares the outcomes of hyperthermic intraperitoneal chemotherapy after primary vs interval
Cancerof the lung, like allcancers, results from an abnormality in the body's basic unit of life, the cell. Normally, the body maintains a system of checks and balances on cell growth so that cells divide to produce new cells only when new cells are needed. Disruption of this system of...